Citizens' Attitudes, Knowledge, and Educational Needs in the Field of Omics Sciences: A Systematic Literature Review by Calabro, G. E. et al.
SYSTEMATIC REVIEW
published: 23 October 2020
doi: 10.3389/fgene.2020.570649







Leibniz University Hannover, Germany
Gabriele Werner-Felmayer,




†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
ELSI in Science and Genetics,
a section of the journal
Frontiers in Genetics
Received: 08 June 2020
Accepted: 22 September 2020
Published: 23 October 2020
Citation:
Calabrò GE, Sassano M, Tognetto A
and Boccia S (2020) Citizens’
Attitudes, Knowledge, and
Educational Needs in the Field of




Citizens’ Attitudes, Knowledge, and
Educational Needs in the Field of
Omics Sciences: A Systematic
Literature Review
Giovanna Elisa Calabrò 1*†, Michele Sassano 1†, Alessia Tognetto 1 and Stefania Boccia 1,2
1 Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome,
Italy, 2Department of Woman and Child Health and Public Health–Public Health Area, Fondazione Policlinico Universitario
A. Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy
Background: The huge development of omics sciences is changing the classical
medical approach and making new technologies available. In this context, education
of citizens is essential to allow appropriate decisions about their own health. Hence,
we aimed to summarize existing literature regarding citizens’ knowledge, attitudes, and
educational needs on omics sciences.
Methods: We performed a systematic literature review (SLR) using Pubmed, ISI Web of
Science, and Embase databases. The eligibility criteria for inclusion in this review required
that the studies investigated knowledge, attitudes, or educational needs regarding omics
sciences among the general population.
Results: We included 54 studies, published between 2006 and 2020. Most of the
included studies (72%) investigated citizens’ knowledge, half of them (56%) attitudes,
and 20% educational needs in the field of omics sciences, while 52% investigated
attitudes and perceptions about genetic and/or omics tests. Most studies (64%) reported
a limited knowledge level among citizens, even though most (59%) reported participants
understood the benefits of the use of omics sciences into medicine. As for omics tests,
a controversial opinion toward their use into practice was reported among citizens. Most
of the studies (82%) investigating citizens’ educational needs highlighted a clear gap to
be filled.
Conclusions: Our SLR summarizes current knowledge on citizens’ literacy, attitudes,
and educational needs on omics science, underlining the need for strengthening public
engagement on this topic. Further research is needed, however, to identify appropriate
methods and models to achieve such an improvement.
Keywords: citizens’ literacy, omics sciences, genetic/omics knowledge, public attitudes, educational needs,
systematic review, personalized medicine
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INTRODUCTION
Rapid growth in genetic and genomic research has transformed
our understanding of the role of genes in health and disease. The
historical focus of genetic research has been on rare, single-gene
disorders, in which disease risk is largely based on the presence
or absence of a mutation in a single associated gene. This focus
has been greatly expanded in recent years (Lea et al., 2011).
Research in genomics is now examining the genetic components
of common, complex diseases, such as cancer, diabetes, heart
disease, etc. For these diseases, the contributions of single genes
to risk are often small in comparison to the rare, inherited
diseases, and disease risk is based on multiple genetic and
environmental factors. These aspects highlighted the complexity
of biological systems and provided new approaches to diseases
diagnosis, treatment, and prevention (Lea et al., 2011).
Since the mapping of the human genome in 2003
(International Human Genome Sequencing Consortium,
2004), important progress has been made in understanding
molecular and genetic pathways underpinning human health
and diseases, promoting the development and the diffusion of
genomics and of other omics sciences and related technologies.
In the last two decades, the use of words ending in “-
omics” has extended, from the initial “genomics,” to a wide
range of biomolecular disciplines addressed to the study of
specific aspects considered as a whole. Therefore, the omics
sciences study pools of biological molecules (e.g., ions, nucleic
acids, proteins, enzymes) with various functions within living
organisms and have the primary objective to analyze as a
whole e.g., genes contained in DNA (genomics) and their
multiple functions (functional genomics), DNA transcription
product–RNA- (transcriptomics), proteins encoded by DNA
through RNA (proteomics), molecules that interact within an
organism or metabolites (metabolomics) (Lin and Qian, 2007;
Tebani et al., 2016). Among the other goals of these sciences
is also to study the connections and reciprocal interactions
between the pool of biological molecules (interactomics) and
between these molecules and microorganisms of the intestinal
flora (microbiomics), foods and/or nutrients (nutribiomics)
(Coughlin, 2014).
Since then, the Human Genome Project (HGP) was
followed by other relevant initiatives, such as International
HapMap Project (The International HapMap Consortium,
2003), ENCyclopedia of DNA Elements (ENCODE) Project
(ENCODE Project Consortium, 2004), 1’000 Genome Project
(1000 Genomes Project Consortium et al., 2015), and 100’000
Genome Project (Turnbull et al., 2018; Genomics England,
2019a,b). The importance of genetic factors in determining
disease risk was understood by various European and not
European governments and Institutions. To this end, a number
of projects were put in place in the world, some of them even
before HGP: for example, the Icelandic company deCODE,
around 1996, announced a plan to genotype the entire national
population (An, 2017).
Hence, an exponential growth of knowledge took place,
first in genomics and later in other omics sciences too. As
a consequence, new technologies, such as Next-Generation
Sequencing (NGS), are nowadays available. These high-
throughput omics technologies simultaneously measure
thousands of data providing detailed information of cells,
organisms, and populations and contributing to the definition of
new diagnostic tests, new biomarkers and new drugs in the era
of precision medicine (Tebani et al., 2016). These new second
generation technologies led to an important cost reduction
compared to the past (van Dijk et al., 2014), allowing then
an increased accessibility to genomics testing and a potential
improved sustainability by health systems. Therefore, during last
years, a growing and uncontrolled availability of genetic tests,
not only for monogenic disorders but also for multifactorial
ones, took place and this progress in the genomics field had
evident implications for public health, bringing important
benefits but also potential risks for the population. A perfect
example in this sense is given by direct-to-consumer genetic
tests (DTC-GTs), which are tests sold by companies directly to
consumers, without the involvement of a health professional (Su,
2013). In particular, besides potential discriminatory and privacy
issues, not always properly addressed by laws and regulation
(Kalokairinou et al., 2018; Hoxhaj et al., 2020), citizens don’t have
competencies needed to understand of results of these genetic
tests, thus possibly leading to further unnecessary diagnostic
investigation and, finally, waste of healthcare resources (Borry,
2010; Su, 2013). Furthermore, literature data suggest that
knowing own genetic risk for specific diseases could lead to
psychological distress, even though there are not clear evidence
yet (Su, 2013).
All these aspects highlight the importance of counseling
by trained health professionals and of appropriate citizens’
education about omics sciences and new technologies related to
them. Previous reviews report conflicting results about citizens’
knowledge in the field of genetics, genomics, and DTC-GTs
(Covolo et al., 2015; Hoxhaj et al., 2019; LePoire et al., 2019), even
though with positive attitudes (Covolo et al., 2015; American
Society of Human Genetics, 2020).
However, to our knowledge, no previous systematic review
attempted to assess citizens’ knowledge and attitudes in the wide
field of omics sciences. Furthermore, we do not yet have adequate
information on the educational needs of the general population
in this field and on the topics of greatest interest to citizens.
Hence, to address these issues, our aim was to systematically
summarize the existing evidence about knowledge, attitudes,




An online search was conducted using the following electronic
databases: Pubmed, ISI Web of Science and Embase. The search
was limited to articles published in English language from
January 1, 2003, until May 31, 2020. We used the following
terms for the literature search in MEDLINE database: (“omics”
OR “genomics” OR “omics sciences”) AND (“knowledge” OR
“opinion” OR “perception” OR “awareness” OR “education” OR
“literacy”) AND (“citizen∗” OR “population” OR “public”). This
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search strategy was also used as template for the search in the
other databases.
Three researchers (GEC, MS, AT) independently reviewed
titles, abstracts, and full texts of the retrieved papers in order
to identify the eligible studies. Results were cross-checked
and any disagreement was resolved through discussion until
consensus was reached. The snowball strategy, a manual search
of the references reported by studies retrieved from the online
databases, was also adopted to identify additional studies. The
systematic review was drafted in accordance with PRISMA
guidelines (Moher et al., 2009).
Eligibility Criteria
Studies that investigated knowledge, attitudes (in terms
of perceived benefits and/or risks), or educational needs
regarding omics sciences among the general population were
deemed as eligible. We excluded commentaries, editorials,
conference abstracts, reviews, case reports, case series, and book
chapters, and articles addressing a population of researchers or
professionals only.
Data Extraction
From each eligible study we extracted information on Country,
promoter of the initiative, duration and aim of the initiative,
topic, target population and age, methods/initiative description
and initiative type, awareness on genetics/omics sciences,
perceived benefits on the use of genetics/omics sciences in
medicine, worries about the use of genetics/omics sciences
in medicine, perceptions about genetic/omics tests, need for
more education/information regarding omics sciences among
the population.
Results are presented according to the three major areas
investigated across the studies, namely knowledge, attitudes and
educational needs about omics sciences and genetic and/or
omics tests.
RESULTS
Study Selection and Characteristics of
Included Studies
Electronic databases search led to the identification of 1,948
articles (381 from Pubmed, 582 from ISI Web of Knowledge,
FIGURE 1 | Study selection process flowchart.
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and 985 from Embase). After duplicates removal and title and
abstract screening, 99 articles were selected. From these, after
full-text analysis 51 studies were removed, while 6 additional
studies were retrieved though snowball search of reference lists
of included articles.
After the latest selection process, 54 articles responded to
eligibility criteria and were included in the systematic literature
review. The Figure 1 shows study selection process, as indicated
by PRISMA guidelines (Moher et al., 2009), while Table 1 reports
main characteristics of included studies.
The articles included in this systematic review were published
between 2006 and 2020. Among the 54 included studies, 44%
were conducted in USA (n = 24) (Fomous et al., 2006; Goddard
et al., 2007, 2009; Gleason et al., 2010; Hahn et al., 2010; Lemke
et al., 2010; East et al., 2012; Kaphingst et al., 2012, 2015, 2016;
Kolor et al., 2012; Haga et al., 2013; Almeling, 2014; Borzekowski
et al., 2014; Waters et al., 2014, 2016, 2017; Abrams et al., 2015;
Dodson et al., 2015; Graves et al., 2015; Schmidlen et al., 2016;
Ahmed et al., 2017; Krakow et al., 2017; Horrow et al., 2019),
22% (n = 12) in the European Union (EU27) (Henneman et al.,
2006, 2013; Calsbeek et al., 2007; Morren et al., 2007; Mai et al.,
2011; Smerecnik et al., 2011; Dijkstra et al., 2012; Vermeulen
et al., 2014; Mavroidopoulou et al., 2015; McCormack et al., 2016;
Fournier and Poulain, 2018; Rebitschek et al., 2019), 9% (n = 5)
in Canada (Morin, 2009; Nielsen and El-Sohemy, 2012; Bombard
et al., 2013; Nicholls et al., 2013; Etchegary et al., 2015), 6% (n =
3) in UK (Skirton et al., 2006; Sturgis et al., 2010; Jones et al.,
2019), 6% (n = 3) in various countries (Stewart-Knox et al.,
2009; Pereira et al., 2019; Middleton et al., 2020), 4% (n = 2) in
Australia (Molster et al., 2009; Metcalfe et al., 2018), 4% (n = 2)
in Japan (Ishiyama et al., 2008; Miyamoto et al., 2016), 2% (n =
1) in Israel (Simonstein andMashiach-Eizenberg, 2016), 2% (n=
1) in Russia (Makeeva et al., 2009) and, eventually, 2% (n= 1) in
Switzerland (Mählmann et al., 2016).
Regarding the target population, most of studies (76%)
addressed samples representative of the general population
(Fomous et al., 2006; Henneman et al., 2006, 2013; Goddard
et al., 2007, 2009; Ishiyama et al., 2008; Makeeva et al., 2009;
Molster et al., 2009; Morin, 2009; Stewart-Knox et al., 2009;
Hahn et al., 2010; Lemke et al., 2010; Sturgis et al., 2010; Mai
et al., 2011; Smerecnik et al., 2011; Dijkstra et al., 2012; East
et al., 2012; Kolor et al., 2012; Nielsen and El-Sohemy, 2012;
Bombard et al., 2013; Haga et al., 2013; Nicholls et al., 2013;
Almeling, 2014; Borzekowski et al., 2014; Vermeulen et al., 2014;
Waters et al., 2014, 2016; Abrams et al., 2015; Dodson et al., 2015;
Etchegary et al., 2015; Graves et al., 2015; Miyamoto et al., 2016;
Schmidlen et al., 2016; Simonstein and Mashiach-Eizenberg,
2016; Ahmed et al., 2017; Krakow et al., 2017; Fournier and
Poulain, 2018; Metcalfe et al., 2018; Jones et al., 2019; Rebitschek
et al., 2019; Middleton et al., 2020), while the remaining part
involved samples selected based on demographic characteristics
(detailed description in Table 1).
In most cases (59%) the initiatives described were promoted
by universities (Fomous et al., 2006; Henneman et al., 2006;
Skirton et al., 2006; Morren et al., 2007; Morin, 2009; Stewart-
Knox et al., 2009; Hahn et al., 2010; Mai et al., 2011; Smerecnik
et al., 2011; Nielsen and El-Sohemy, 2012; Bombard et al.,
2013; Haga et al., 2013; Nicholls et al., 2013; Almeling, 2014;
Borzekowski et al., 2014; Vermeulen et al., 2014; Waters et al.,
2014, 2016, 2017; Dodson et al., 2015; Etchegary et al., 2015;
Graves et al., 2015; Kaphingst et al., 2015, 2016; Mavroidopoulou
et al., 2015; Mählmann et al., 2016; Miyamoto et al., 2016;
Schmidlen et al., 2016; Simonstein and Mashiach-Eizenberg,
2016; Fournier and Poulain, 2018; Metcalfe et al., 2018).
Overall, 72% of included studies (n= 39) investigated citizens’
knowledge (Table 2), 56% (n = 30) attitudes (Table 3), and
20% (n = 11) educational needs (Table 2) in the field of
omics sciences, while 52% (n = 28) investigated attitudes and
perceptions about genetic and/or omics tests (Table 4). To this
end, tools such as questionnaires or surveys were used in 74% (n
= 40) of studies (Henneman et al., 2006, 2013; Calsbeek et al.,
2007; Goddard et al., 2007, 2009; Morren et al., 2007; Ishiyama
et al., 2008; Makeeva et al., 2009; Molster et al., 2009; Stewart-
Knox et al., 2009; Sturgis et al., 2010; Mai et al., 2011; Smerecnik
et al., 2011; Dijkstra et al., 2012; East et al., 2012; Kaphingst et al.,
2012, 2015, 2016; Kolor et al., 2012; Nielsen and El-Sohemy,
2012; Haga et al., 2013; Almeling, 2014; Borzekowski et al.,
2014; Vermeulen et al., 2014; Waters et al., 2014, 2016; Abrams
et al., 2015; Dodson et al., 2015; Etchegary et al., 2015; Graves
et al., 2015; Mavroidopoulou et al., 2015; Mählmann et al., 2016;
Miyamoto et al., 2016; Schmidlen et al., 2016; Simonstein and
Mashiach-Eizenberg, 2016; Krakow et al., 2017; Horrow et al.,
2019; Jones et al., 2019; Pereira et al., 2019; Middleton et al.,
2020). Instead, 26% (n =14) reported residential methods, such
as meetings, workshop, or focus groups (Skirton et al., 2006;
Morin, 2009; Hahn et al., 2010; Lemke et al., 2010; Bombard et al.,
2013; Nicholls et al., 2013; Etchegary et al., 2015; McCormack
et al., 2016; Ahmed et al., 2017; Waters et al., 2017; Fournier and
Poulain, 2018; Metcalfe et al., 2018; Jones et al., 2019; Rebitschek
et al., 2019). Furthermore, in 4% of the studies (n = 2) a course
was developed (Gleason et al., 2010; East et al., 2012), while in 4%
of cases (n = 2) a movie or a short video was realized (Sturgis
et al., 2010; Mählmann et al., 2016). Lastly, one study (2%)
involved the online consultation of a web portal on genomics and
its implications (Fomous et al., 2006), and in another one (2%),
focused on nutrigenomics, a clinical trial was carried out (Nielsen
and El-Sohemy, 2012).
Finally, all the studies included in our systematic review
deal with topics related to genomics and genetics or genetic
tests, while we found none related to omics in general or to
other specific branch of omics sciences such as metabolomics
or proteomics.
Knowledge
Among studies investigating citizens’ knowledge, 31% (n = 12)
aimed to evaluate knowledge on basic concepts in genetics among
the general population (Fomous et al., 2006; Skirton et al., 2006;
Calsbeek et al., 2007; Ishiyama et al., 2008; Molster et al., 2009;
Sturgis et al., 2010; Mai et al., 2011; East et al., 2012; Abrams
et al., 2015; Miyamoto et al., 2016; Simonstein and Mashiach-
Eizenberg, 2016; Jones et al., 2019) (Table 2). More than half
of the identified studies (72%, n = 28), instead, investigated
knowledge of the population on genetic and/or genomics tests
(Henneman et al., 2006, 2013; Skirton et al., 2006; Goddard et al.,
































TABLE 1 | Studies included in the systematic literature review and their main characteristics.
References Country Initiative
funder/promoter/supporter
Aims and methods Target population Age
Fomous et al.
(2006)
USA University Improvement of understanding about genomics and
implications of the Human Genome Project on public health





Netherlands University Assessment of attitudes toward availability and use of
genetic tests through a questionnaire
General population (N = 817) Males: mean: 57.6 years,
range: 27–90 years




UK University Assessment of the understanding of genetics and of
attitudes toward genetic tests for clinical and research
purposes, through 2 focus groups lasting 1.5–2 h each
Older adults (N = 7 e 10 in 2
focus groups)
≥65 years (68–90 years
in group 1;
68–82 years in group 2)
Calsbeek et al.
(2007)
Netherlands Panel of Patients with Chronic
Diseases is supported by ministerial
funding
Assessment of genetic knowledge, attitudes toward genetic
tests, and their relations and changes over time, through
postal questionnaires administered in 2002 and 2004
Patients with asthma, diabetes
mellitus and cardiovascular
disease (1st survey−2002 N =




USA Partially supported by Centers
Disease Control and Prevention and
by American Society of Human
Genetics in Public Health Genomics
Research and Practice
Assessment of awareness regarding nutrigenomics DTC
tests through questionnaire
General population (N = 5250) ≥18 years
Morren et al.
(2007)
Netherlands University Assessment of knowledge and attitudes regarding genetics
and genetic tests through a postal questionnaire





Japan Supported by KAKENHI (research
grant) by the Ministry of Education,
Culture, Sports, Science, and
Technology of Japan
Assessment of attitudes toward the promotion of genomics
studies and relation between attitudes and the level of
genomics literacy through a postal questionnaire
General population (N = 2171) 20–69 years
Goddard et al.
(2009)
USA State health departments, Behavioral
Risk Factor Surveillance Systems
(BRFSS)
Assessment of knowledge and use of nutrigenomics DTC
tests through questionnaire
General population
(Oregon N = 1867;
Michigan N = 5499;
Utah N = 2441;




Russia Partly supported by Russian
Foundation for Basic Research and
SB RAMS Medical Genetics
Research Institute
Assessment of attitudes and beliefs toward genetic tests
and genetic research through questionnaire
General population (N = 2000) <24 years: 27.4%
25–39 years: 43.2%
40–64 years:
27.9% ≥65 years: 1.5%
Molster et al.
(2009)
Australia Office of Population Health Genomics,
Health Policy and Clinical Reform
Division, Department of Health
Assessment of knowledge regarding human genetics and
health by telephone survey
General population (N = 1009) ≥18 years
Morin (2009) Canada University Assessment of knowledge and attitudes regarding
nutrigenomics and nutrigenetic tests, through 12 focus
groups lasting 2 h each preceded by a short questionnaire




















































































TABLE 1 | Continued
References Country Initiative
funder/promoter/supporter







University Assessment of attitudes toward genetic and nutrigenomics
tests and personalized nutrition through a survey
General population (N = 5967) ≥14 years
Gleason et al.
(2010)
USA Course funded by Grant by U.S.
Department of Education and GCSU
Science Education Center
Improvement of genetic knowledge and awareness about
ethical, legal, and social implications (ELSI) of Human
Genome Project through an interdisciplinary course
Teachers (biology teachers N =
8; English teachers N = 8)
–
Hahn et al. (2010) USA University Assessment of awareness and perceptions regarding
genomics medicine and preferences related to educational
strategies and contents through 13 focus groups lasting 1 h
each
General population (N = 121) –
Lemke et al.
(2010)
USA Funded by National Human Genome
Research Institute
Assessment of attitudes and perceptions regarding
collection and sharing of genetic research data, through 6
focus groups lasting 1–2 h each
General population (N = 28) and





UK – Assessment of the effect of information provided by a short
film (extended version of 9min and short version of 5min
and 40 s) on opinions regarding genomics through a survey
General population (1st phase N
= 3270; 2nd phase N = 867; 3rd
phase N = 458)
–
Mai et al. (2011) Greece Partially funded by Golden Helix
Institute of Biomedical Research and
research budget of the University of
Patras
Assessment of awareness and perceptions regarding
issues related to genetics, genetic tests, and their impact
on society through a survey
General population (N = 1717) ≥18 years
Smerecnik et al.
(2011)
Netherlands University Assessment of knowledge about genetic risk factors of
multifactorial diseases through online questionnaire
General population (N = 1624) ≥20 years
Dijkstra et al.
(2012)
Netherlands Financially supported by the Dutch
Research Organization, in particular
by the Societal and Ethical Aspects of
Genomics program
Assessment of participation and attitudes toward genomics
research and related problems through online survey
General population (N = 986),
members of the public with
experience in genomics research
as patients (N = 41), patients
with celiac disease (N = 68),
experts (N = 45).
18–65 years
East et al. (2012) USA HudsonAlpha faculty Improvement of genomics literacy through a short course
(three editions), with assessment of learning through pre-
and post-course tests
General population
(1st course N = 110;
2nd course N = 86;
3rd course N = 196;









USA Supported by Intramural Research
Program del National Human
Genome Research Institute, National
Institutes of Health
Assessment of knowledge about genome sequencing and
of the influence of informed consent process on them
(discussion with a geneticist lasting 60–90min) through pre-
and post-discussion questionnaires
ClinSeqTM participants
(sequencing study) (N = 311)
–
Kolor et al. (2012) USA Lifestyle surveillance system Assessment of awareness and use of DTC genetic tests
through telephone survey
General population (Connecticut
N = 6019; Michigan N = 5883;
Oregon N = 1931; Utah N =



















































































TABLE 1 | Continued
References Country Initiative
funder/promoter/supporter
Aims and methods Target population Age
Nielsen and
El-Sohemy (2012)
Canada University Assessment of awareness, perceptions, and understanding
of nutrigenomics and genetic tests through a questionnaire,
and of the influence of personalized dietary advice based on
the genotype on participants’ opinions through a
randomized trial
Toronto Nutrigenomics and






Assessment of perspectives about ethical and social issues
raised by personalized medicine and genetic tests through
meetings preceded by an expert explanation
Citizens panel (N = 14) 18–71 years
Haga et al. (2013) USA University Assessment of knowledge, attitudes, and expectations on
health, genetics, and genetic tests, and of understanding
and perceptions of genomic risk for Type 2 Diabetes
Mellitus through 3 questionnaires
General population (N = 300) ≥18 years
Henneman et al.
(2013)
Netherlands Financially supported by Netherlands
Genomics Initiative
Assessment of experiences, beliefs, and expectations
regarding genetic tests over the years through surveys
administered in 2002 and 2010
Consumers panel (2002 survey
N = 817; 2010 survey N = 978)




Canada University Assessment of the usefulness perception of genomics
applied to cancer and neonatal screening, through 8
workshops/seminars
General population (N = 170) 27–88 years
Almeling (2014) USA University Assessment of opinions regarding policy issues in genetics
and genomics through online survey, in which each
participant was asked to respond imagining that he had an
increased genetic risk for a specific disease
General population (N = 2100) –
Borzekowski et al.
(2014)
USA University Assessment of public reaction to the history of Angelina
Jolie’s preventive mastectomy and of the knowledge about
breast cancer risk in carriers of mutations of the BRCA
gene through online survey
General population (N = 2572) ≥18 years
Vermeulen et al.
(2014)
Netherlands University Assessment of attitudes and interests toward genetic tests,
in particular for prevention of chronic diseases, through a
questionnaire




USA University Assessment, through questionnaire, of: -attitudes in
searching for information about chronic diseases
and cancer -level of knowledge about their multifactorial
etiopathogenesis and the role of genetic factors -relations
between attitudes and knowledge
General population (N = 3630) ≥18 years
Abrams et al.
(2015)
USA Funded by Intramural Research
Program of National Human Genome
Research Institute
Assessment of literacy on genetics, genomics, and genetic
tests through electronic questionnaires
Consumers panel representative





USA University Assessment of interest in whole-genome sequencing
(WGS) through online survey, with specific questions for
parents regarding their children
General population (parents and




Canada University Assessment of attitudes and expectations regarding
genomics research through meetings (5 meetings lasting
1.5 h each) in which slides were shown to stimulate
discussion


















































































TABLE 1 | Continued
References Country Initiative
funder/promoter/supporter
Aims and methods Target population Age
Graves et al.
(2015)
USA Funded by Mayo Clinic Center for
Individualized Medicine
Assessment, through online survey, of perceptions and
attitudes regarding disease actionability and severity, and of
experience and interest in knowing results of genetic tests
General population (N = 900) 18–70 years
Kaphingst et al.
(2015)
USA University Assessment, through questionnaire, of effects of the type of
risk assessment carried out (family history assessment or
genetic test results), the type of disease (cardiovascular
disease or diabetes), and ethnicity on the attitudes
regarding the genetic risk for complex diseases and genetic
testing
Medically underserved




Greece University Assessment of awareness, interest, motivation, and
understanding of DTC genetic tests through questionnaire
University students,
postgraduates and doctoral




USA University Assessment, through survey, of the association between
health literacy and knowledge, perceived importance, and
attitudes on the communication of genetics, family history
and genome sequencing
Medically underserved




Switzerland University Assessment, through a questionnaire, of attitudes toward
personal genomics and genetic tests, after the view of a
movie on the topic
Older adults attending university




Europe Supported by Medical Research
Council UK and European Union
Seventh Framework Programme
Assessment of attitudes regarding participation in genomics
research, large-scale international databases, and sharing
of biological samples, through 5 focus groups lasting
1–1.5 h each





Japan University Assessment of experiences and attitudes toward genomics
and an ongoing genomic cohort study, through a postal
questionnaire
General population (N = 1477) 30–69 years
Schmidlen et al.
(2016)
USA University Assessment of knowledge on the association between
genetic risk and complex diseases and between drug
response and genetic susceptibility, through online
questionnaire
General population (N = 2839),
patients with prostate or breast
cancer (N = 82), patients with
hypertension or congestive heart
failure (N = 201), medical and






Israel University Assessment, through questionnaire, of attitudes toward
genetic technologies, and their correlation with the
understanding of genetics, reproduction and reproductive
risk
Israeli Arabs and Jews (N = 203) ≥19 years
Waters et al.
(2016)
USA University Assessment, through questionnaire, of attitudes in
searching for information about cancer, of knowledge on its
multifactorial etiopathogenesis and on the role of genetic
factors, and of relation between attitudes and knowledge


















































































TABLE 1 | Continued
References Country Initiative
funder/promoter/supporter
Aims and methods Target population Age
Ahmed et al.
(2017)
USA – Improvement of scientific and genetic literacy through
Science Cafés held by experts
General population (Total N =
457; Health Science Cafés N =
248; Genomics Science Cafés N
= 209)
19–39 years: 20.2% 40–59
years: 32% ≥60 years: 47.9%
Krakow et al.
(2017)
USA Government Assessment, through survey, of knowledge and awareness
of genetics, and of use of genetic tests
General population (N = 3285) ≥19 years
Waters et al.
(2017)
USA University Identification of gaps in understanding and acceptance of
research and genomics information through 13 focus
groups, lasting 1–1.5 h each, during which a video with
genetic information was shown and then participants were
asked to discuss it
African American and white




France University Assessment of knowledge and reactions toward nutritional
genomics and epigenomics, food practices, food-health
relation through 3 focus groups, lasting 2.5 h each
General population (N = 22) Mean: 43 years 20–29 years:
9.1%; 30–39 years: 31.8%;
40–49 years: 31.8%; 50–59
years: 18.2%; ≥60 years: 9.1%
Metcalfe et al.
(2018)
Australia University Assessment, through focus groups, of awareness,
knowledge, attitudes and opinions regarding personal
genetic tests
General population (N = 56) ≥18 years
Horrow et al.
(2019)
USA Supported by a grant of the National
Human Genome Research Institute
and the Mayo Clinic Center for
Individualized Medicine
Development of a scale to evaluate attitudes about the
future of genomics medicine (questionnaire)
Participants in a genomic
sequencing study (N = 2895)
26–71 years
Jones et al. (2019) UK Funded by the UK Medical Research
Council
Assessment, through a series of 8 public workshops and a
questionnaire, of public views on access models for reusing
genomics data collected for research in conjunction with
health data
College students, university staff
and students, business
professionals, general public
consumer panel, science festival
attendees, health professionals,
and University of Third Age
members (N = 116)
16–25 years: 18.9%; 26–35
years: 31.8%; 36–45 years:
15.5%; 46–55 years: 9.4%;






Funded by National Institutes of
Health (NIH)/National Heart, Lung,
and Blood Institute (NHLBI) grant
Assessment of perceptions toward pharmacogenetic
testing of patients undergoing percutaneous coronary




intervention (Baseline survey: N
= 1,327 Follow-up survey: N =
860)
Mean: 62.8 years ≤55 years:
27%; 56–65 years: 32%; 66–75
years: 27%; >75 years: 14%
Rebitschek et al.
(2019)
Germany Funded by the European Commission
and supported by The Eve Appeal
Assessment, through 4 focus groups, of what women want
to know about epigenetic cancer risk assessment, how
they evaluate its usefulness, and how they would like to be
informed about their risk








Supported by Well-come grant to the
Society and Ethics Research Group,
Connecting Science, Well-come
Genome Campus, Cambridge, UK.
Also supported by Global Alliance for
Genomics and Health
Assessment, though a survey, of public perceptions of
genomics data sharing
General population (N = 8,967) ≤30 years: 23.3%; 31–40 years:
22.8%; 41–50 years: 17.5%;


















































































TABLE 2 | Citizens’ knowledge and educational needs in the field of omics sciences (where investigated).
References Awareness and knowledge about genomics/omics sciences Factors affecting knowledge Request or need for more education/information
regarding genomics/omics sciences by the population
Skirton et al. (2006) Very low.
Participants were largely unsure about the underlying scientific basis
of genetics.




Better knowledge on association between genes and diseases. Perceived





14% of participants aware of DTC nutrigenomics tests; 15% aware of
pharmacogenetic tests; 30% aware of genetic tests to assess disease risk;
38% aware of genetic tests to diagnose diseases. Main sources of
information on DTC nutrigenetic tests: television (46%), magazine (35%),
newspapers (29%).
– –
Morren et al. (2007) Low.
Most of the respondents reported having poor knowledge of genetics
(about 10% reported having knowledge about it, while half to three quarters





Extremely variable level of knowledge and understanding (the percentage of
correct answers varies between 12.7% and 71.9% depending on






Estimates of awareness about direct-to-consumer nutrigenomics test
ranged from 7.6% in Michigan to 24.4% in Oregon.
– –
Molster et al. (2009) Low.
46% said they knew very little about human genes and health.
– –
Morin (2009) Low.
Limited knowledge about current nutrigenomics practices.
– More public education on nutrigenomics needed.
Gleason et al. (2010) Low, heterogeneous. Before the course, Biology teachers had better
knowledge, while English ones very poor knowledge. After the course,
participants showed significant improvements in knowledge about genetics
and the Human Genome Project.
– –
Hahn et al. (2010) Low.
Most participants never even heard the term “genomics medicine.” Most
were unfamiliar with the term “personalized medicine.”
– Willingness to know more about specific diseases, use in
research, cloning and genetic engineering.
Lemke et al. (2010) Low, heterogeneous.
Variable and scarce knowledge on genomics research: in most cases
participants associated genetic research only with diseases, few knew of
basic research.
– Willingness to receive more information on genetic research,
as it was considered important for reducing fears and
increasing confidence. It is important to increase awareness
in isolated groups (low income, minorities), young people,
schools, neighborhoods and disease support groups.
Suggested strategy was to target populations at greater risk
for a given condition than the general population. Other




















































































TABLE 2 | Continued
References Awareness and knowledge about genomics/omics sciences Factors affecting knowledge Request or need for more education/information
regarding genomics/omics sciences by the population
Mai et al. (2011) Moderate.
Most of participants were aware of simple concepts of general genetics and
genetic testing.
Poorer knowledge with increasing age and in





17.9% said they heard of genetic risk factors for multifactorial diseases.
– –
Dijkstra et al. (2012) Low.
Poor knowledge about genomics research (24.2% never read information
on genomics research, 54.1% sometimes).
– Most of participants never searched for information about
genomics research (71.4% never searched for information on
the internet or library).
East et al. (2012) Low/very low before the course.
Course led to a significant improvement of perceived knowledge
– Participants reported a high likelihood for continued
self-learning after the course.
Kaphingst et al.
(2012)
Heterogeneous. Level of knowledge on limits and benefits of sequencing
was very variable before starting the study. Knowledge increased
significantly from pre to post informed consent.
Level of knowledge related to the level of
education.
–
Kolor et al. (2012) Heterogeneous.
DTC-GT awareness ranged from 15.8% in Michigan to 29.1% in Oregon.
The most commonly cited source from which respondents read or heard of











– – Participants called for increased public awareness about
personalized medicine to increase confidence and use of new
technologies, in addition to counseling services.
Haga et al. (2013) Moderate.
Participants scored significantly higher on questions related to heredity and
causes of diseases (average score of 94.6%) compared to questions on
genes, chromosomes and cells (average score of 78.6%). Most of






Awareness about genetic testing and genetic diseases did not change
between 2002 and 2010.
– –
Almeling (2014) Low.






Less than 10% knew the average risk of breast cancer in the general
population and the fraction of breast cancers due to BRCA mutations.
Knowledge of Angelina Jolie’s story was not




















































































TABLE 2 | Continued
References Awareness and knowledge about genomics/omics sciences Factors affecting knowledge Request or need for more education/information
regarding genomics/omics sciences by the population
Waters et al. (2014) Moderate-high.
Most of participants (64.2–78.6%) reported awareness of the multifactorial
etiopathogenesis of diseases.
– –
Abrams et al. (2015) Moderate.
Participants were “somewhat familiar” with genomics terms presented.
Average score in the assessment of skills resulted 4 out of 6 correct
answers, while on average participants correctly identified 8 out of 16 facts.
Level of knowledge related to the level of
education.
–
Dodson et al. (2015) Moderate.
About 58.6% of respondents expressed some interest in whole genome
sequencing, especially in those who expressed interest in having a child in





Many participants noted they lacked knowledge about genetics and
associated research.
– Participants reported the necessity for accurate information to
make informed decisions both about genetic testing and
participation in genetics research.
Kaphingst et al.
(2015)
– – Strong interest in receiving a genomics evaluation for
reference diseases (diabetes/heart disease), in discussing
genomics information with family members and a doctor, and




43.7% of the participants had the perception of being lacking in basic





On average, participants answered 3 out of 5 questions regarding
genomics correctly.











Adopted scale and frequency of participants in each group: “High” level of
knowledge: understanding of the terms genome and gene or understanding
of the term “gene” and having heard of “genome” = 30.2%; “Medium” level:
having heard of both terms or understanding the term “gene” and having
never heard of “genome” = 35.7%; “Low” knowledge consisted of having






Average genetic knowledge score among participants: 76%.
Higher level of knowledge in those who had
previous experiences in genetic education
(genetics courses, website consultations and






Most participants did not understand basic level questions in the general
understanding of genetics section. 47.6% correct answers in the general





















































































TABLE 2 | Continued
References Awareness and knowledge about genomics/omics sciences Factors affecting knowledge Request or need for more education/information
regarding genomics/omics sciences by the population
Waters et al. (2016) Moderate.
Participants had relatively high previous experience with cancer, through
family history (66.5%) or awareness about DTC genetic tests (51.1%).
– –
Ahmed et al. (2017) Low.
However, Science Café model led to a change in participants’ perceived
literacy level.
Individuals with middle or high socioeconomic
status perceived a greater change, while a level
of education beyond high school was
associated with greater difficulty in increasing
literacy.
–
Krakow et al. (2017) Moderate, referred to genetic tests.
57% of participants were aware of genetic tests.
– –
Waters et al. (2017) Low.
Beliefs were not always consistent with biomedical explanations about the




– – Many doubts about nutrigenetic tests and, therefore, a need
for information on regulation, scientific evidence, medical
support, and costs/economy was expressed.
Metcalfe et al. (2018) Low.
Knowledge about personal genomics tests was poor, but most participants
could guess what the term “personal genomics” could imply. A minority had
heard the term “direct-to-consumer test.”
– –
Horrow et al. (2019) High.
Mean score in the genomic knowledge (knowledge of sequencing
limitations and potential benefits) was 8.1 out of 11.00.
– –
Jones et al. (2019) Low.
6.8% of participants reported no knowledge of genetics, 34.4% little, 36.2%




– – Study participants wanted to understand how the epigenetic
approach is different from established genomics tests, how
epigenetic changes relate to cancer, and whether the test
enables monitoring of one’s cancer risk. Furthermore, they
wanted to know more about basic cancer risks and
information after epigenetic testing about non-invasive




















































Calabrò et al. Citizens’ Literacy on Omics Sciences
TABLE 3 | Citizens’ attitudes on omics sciences (where investigated).
References Perception of benefits in the use of genetics/omics
sciences in medicine




Two hundred and sixty-four supporters vs. 248 against the
availability and use of genetic tests. Forty-three percentage
believed that knowing genetic background of diseases would help
people live longer.
Among respondents, 40% thought that knowing own genetic
makeup would be deterministic for people because it would
decrease their self-esteem and/or deprive people of the freedom
to live as desired. According to 44% of the interviewees, tests
could lead to social exclusion of subjects with positive tests and
handicaps.
Skirton et al. (2006) Enhanced medical knowledge could enable preventive measures
to be taken.
Ethical issues, psychological consequences of genetic test results.
Calsbeek et al. (2007) – Some participants considered genetic tests “frightening”; some
were concerned about insurance consequences of the tests.
Morren et al. (2007) Most of the interviewees (70–80%) approved genetic tests and
considered genetic research important for future treatment of
diseases.
Especially consequences in case of positivity to genetic tests for
work and medical insurance.
Ishiyama et al. (2008) Genomic literacy related with positive attitude toward genomic
studies.
–
Makeeva et al. (2009) Among respondents, 81.3% believed that genetics would help
people live longer and 81.4% that would help keep their lifestyle
under control.
Among the participants, 48.0% were worried about discrimination
based on genetic data.
Morin (2009) Consumers believed that potential benefits of nutrigenomics
outweigh risks. For participants, nutrigenomics could also lead to
early diagnosis or disease prevention and, in general, could
encourage healthy eating habits.
Toward online services and DTC genetic tests.
Greater regulatory control is needed to protect consumers (in
particular for sale of genetic tests).
Stewart-Knox et al.
(2009)
Perceived benefits of nutrigenomics to follow a personalized diet. Concerns about how information would be used.
Hahn et al. (2010) For disease prevention and treatment. Affordability, unanticipated physical harm, mistrust of the
government and researchers, downstream effects like
overpopulation, playing God/disturbing the natural order, lack of
regulations, loss of privacy, genetic discrimination, and moral
dilemmas posed by genetic engineering, cloning, choosing traits,
and abortions resulting from genetic information.
Lemke et al. (2010) Among perceived benefits of genomics research there were the
possibility to prevent and treat diseases and potential cost savings
to society.
Concerns about sharing research results with the public,
possibility of discrimination by insurance companies, the
government, the health care system, and employers.
Nielsen and
El-Sohemy (2012)
Nutrigenomics information was considered useful for motivation to
change lifestyle (prevention).
–
Bombard et al. (2013) For disease prediction and treatment. Costs, accessibility, need, and feasibility of introduction into the
health system.
Haga et al. (2013) More than half of participants agreed with the possibility that a
DNA test will change a person’s future (56.3%).
More than half of participants agreed with the possibility that a
DNA test will affect a person’s ability to obtain health insurance
(51.3%), 16% were worried about the consequences of tests on
the possibility to find a job.
Henneman et al.
(2013)
– Some believed that insurance companies will require genetic
testing in the future to determine the premium (36%, <2002).
Nicholls et al. (2013) The application of genomics to screenings could allow early
intervention, prevention, and stricter monitoring.
Costs, educational needs regarding the probabilistic nature of the
risk, access to personal genomics information.
Almeling (2014) Perception of importance/utility (indirectly: 57% agree that the
federal government should spend more on researching the genetic
causes of diseases).
Important to avoid discrimination (82% believe GINA–Genetic
Information Non-discrimination Act 2008–is important).
Vermeulen et al. (2014) Especially interests for preventive genomics. –
Etchegary et al. (2015) Omics sciences perceived as beneficial, but not a priority for the
health system.
Dangerous use of information, privacy issues.
Kaphingst et al. (2015) Black women perceived fewer health benefits than white women;





Most participants expressed interest in undergoing DTC genetic
testing for serious diseases, such as cancer (54.9%), or a
metabolism or genealogy test (50.2%), but would prefer to consult
their doctor first.
Concerns about personal data.
(Continued)
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TABLE 3 | Continued
References Perception of benefits in the use of genetics/omics
sciences in medicine
Concerns about the use of genetics/omics sciences in
medicine
Kaphingst et al. (2016) Fifty four percentage of participants considered genetic
information very important.
–
Mählmann et al. (2016) Participants were interested in personal genomics mostly to find
out about their own disease risk or to contribute to scientific
research.
Concerns and doubts about psychological implications deriving
from testing results, validity of tests, privacy issues.
McCormack et al.
(2016)
Participants understood the importance of sharing data and
samples and creating databases for rare diseases.
Concerns about risks to privacy and autonomy in sharing data on
an international database. Need to limit access to personal data to
health professionals involved in research. All participants were
against access to data by private companies.
Miyamoto et al. (2016) Over 80% of participants agreed that the use of genetic
information for medical purposes is “useful for disease diagnosis,”
“useful for disease treatment” and “useful for disease prevention”
Less than half of respondents showed “concerns” about the use
of genomics in medicine (worries regarded the use of genomics
information by companies or government agencies, possible
discrimination at work and by insurance companies, problems




Most (81.3%) believed that medicine could improve with the use of
genetic engineering.
Almost half of the participants agreed (22.7% partially agreed,
18.7% agreed) with the sentence “genetic engineering could
destroy the human race.”
Fournier and Poulain
(2018)
Nutritional epigenomics was perceived positively compared to
nutritional genomics.
Possible conflicts of interest between scientific research and the
agri-food industry.
Metcalfe et al. (2018) Only for health purposes. Concerns about privacy issues, potential discrimination. Cost
skepticism (speculation by companies) was expressed too.
Horrow et al. (2019) Genomic optimism was positively associated with higher health
literacy.
Genomics pessimism was associated with lower health literacy.
Jones et al. (2019) The majority (67.2%) of questionnaire respondents placed a high
or very high value on using genetic data for research.
Almost half of the respondents reported moderate concern about
the use of genetic data for research (48%). Most commonly
expressed concern was misuse of data tied with concerns about
information governance.
Participants expressed the importance of informed consent for
access to genetic data for research and a preference for a safe
use of the data.
Middleton et al. (2020) – The main potential harm identified was the possibility to use DNA
of other individuals to blame them for a crime (45.2%), insurance
discriminations (37.2%), use of genetic information by companies
for targeted marketing strategies (35%).
2007, 2009; Morren et al., 2007; Makeeva et al., 2009; Stewart-
Knox et al., 2009; Mai et al., 2011; Kaphingst et al., 2012; Kolor
et al., 2012; Haga et al., 2013; Nicholls et al., 2013; Almeling, 2014;
Vermeulen et al., 2014; Abrams et al., 2015; Dodson et al., 2015;
Graves et al., 2015; Mavroidopoulou et al., 2015; Mählmann et al.,
2016; Krakow et al., 2017; Metcalfe et al., 2018; Horrow et al.,
2019) (Table 2).
Thirty-eight percent of the studies (n= 15) evaluated citizens’
knowledge regarding the role of genetic factors in disease risk
(including reproductive risk/fetal disease risk) (Morren et al.,
2007; Makeeva et al., 2009; Molster et al., 2009; Hahn et al., 2010;
Smerecnik et al., 2011; Nicholls et al., 2013; Borzekowski et al.,
2014; Vermeulen et al., 2014; Waters et al., 2014, 2016, 2017;
Abrams et al., 2015; Graves et al., 2015; Schmidlen et al., 2016;
Simonstein and Mashiach-Eizenberg, 2016) (Table 2).
Furthermore, 15% of the studies (n= 6) addressed the ethical,
social and legal implications related to genetic information
(Fomous et al., 2006; Makeeva et al., 2009; Gleason et al.,
2010; Lemke et al., 2010; Bombard et al., 2013; Almeling, 2014;
McCormack et al., 2016). Ten percent (n= 4) of included articles
focused on nutrigenomics and/or nutrigenetic tests (Goddard
et al., 2007, 2009; Morin, 2009; Nielsen and El-Sohemy, 2012).
Lastly, 10% of the studies (n= 4) dealt with the topic of genomics
research (Ishiyama et al., 2008; Lemke et al., 2010; Dijkstra et al.,
2012; Etchegary et al., 2015).
Study participants had, in most cases (64%, n = 25), a limited
knowledge level regarding the abovementioned topics (Skirton
et al., 2006; Calsbeek et al., 2007; Goddard et al., 2007, 2009;
Morren et al., 2007; Ishiyama et al., 2008; Molster et al., 2009;
Morin, 2009; Gleason et al., 2010; Hahn et al., 2010; Lemke et al.,
2010; Smerecnik et al., 2011; Dijkstra et al., 2012; East et al., 2012;
Nielsen and El-Sohemy, 2012; Almeling, 2014; Borzekowski et al.,
2014; Abrams et al., 2015; Etchegary et al., 2015; Mavroidopoulou
et al., 2015; Mählmann et al., 2016; Simonstein and Mashiach-
Eizenberg, 2016; Ahmed et al., 2017; Waters et al., 2017; Metcalfe
et al., 2018; Jones et al., 2019) (Table 2). Instead, few studies
(26%, n = 10) showed a medium or moderate knowledge level
(Henneman et al., 2006; Molster et al., 2009; Haga et al., 2013;
Waters et al., 2014, 2016; Abrams et al., 2015; Dodson et al., 2015;
Kaphingst et al., 2016;Miyamoto et al., 2016; Krakow et al., 2017).
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TABLE 4 | Citizens’ perceptions and attitudes about genetic and/or omics tests (where investigated).
References Perceptions about genetic/omics tests
Henneman et al. (2006) Variable, almost half of respondents neither agreed nor disagreed with the statement that genetic testing carries more benefits than risks.
Skirton et al. (2006) Positive, in particular for disease prevention and prevention for family members.
Calsbeek et al. (2007) Positive, most participants approved genetic testing for the treatment of diseases (78% to 86%) or for early detection of diseases.
However, some concerns were expressed, mostly related to the consequences of DNA-testing for taking out insurances.
Morren et al. (2007) Variable. Just over two thirds said they would like to know if their disease is genetic. Thirty percentage said they did not want to know if
they are at risk of a genetic disorder. If no appropriate treatment was available, over 40% of chronic patients would abstain from genetic
test. Most respondents thought that the family should be informed of test results and would share the results with their children (70%)
and siblings (65%).
Makeeva et al. (2009) Positive, most participants stated that they would undergo tests and change their lifestyle based on the results.
Morin (2009) Positive, nutrigenomics tests could have a positive impact on behavior/lifestyle. Worries about online purchase of genetic tests.




Positive, 66% of participants said they would undergo a genetic test.
Hahn et al. (2010) Variable/with doubts. Positive but with some skepticism.
Mai et al. (2011) Positive, most participants stated that they would undergo a test even if not reimbursed.
Most were against DTC genetic tests, most believed that a doctor should prescribe them and explain results.
Nielsen and El-Sohemy
(2012)
Positive, nutrigenomics knowledge was considered useful to motivate people to change own lifestyle.
Bombard et al. (2013) Variable/with doubts. Positive, but concerns for ethical issues for access to treatments based on genetics were expressed.
Haga et al. (2013) Variable. 52% of participants stated they were interested in genetic testing and 45% said they were extremely interested. Most
participants expressed positive attitudes toward the goals of genetic research and the use of genetic tests.
Henneman et al. (2013) Variable, not everyone agreed that genetic tests make it possible to live longer or that they carry more benefits than harms.
In 2010 more people (compared to 2002) believed that the use of genetic tests should be promoted, although 37% did not agree.
Nicholls et al. (2013) Variable, basically positive attitudes.
Almeling (2014) Most believed that healthcare professionals should be involved in explaining test results.
Vermeulen et al. (2014) Variable. About half of the participants expressed interest in genetic testing for prevention of specific diseases (cancer, cardiovascular
disease, diabetes, or dementia). According to participants, genetic tests should be performed in hospitals (66%) and addressed to
curable (57%) or preventable (69%) diseases. Older participants said they wanted to know only about diseases that can be treated more
often than younger ones (65% vs. 47%).
Etchegary et al. (2015) Controversial, with concerns mostly related to data privacy and possible harmful uses of test results.
Graves et al. (2015) Variable. The existence of a treatment (87%) and the severity of the disease (85%) were considered important in deciding which test
results one wants to know.
Kaphingst et al. (2015) Variable. Greater interest in genomics assessments among those with a limited health literacy.
Mavroidopoulou et al.
(2015)
Positive. Genetic tests must be preceded by medical genetic counseling. Interest in undergoing a DTC genetic test was cost dependent.
Mählmann et al. (2016) Positive, most participants were interested in undergoing genetic testing to know their own disease risk.
Miyamoto et al. (2016) Variable. Positive toward genetic tests for drug susceptibility (48.5% of the interviewees showed positive attitudes, 29.7% did not know




Positive, most supported using genetic testing during pregnancy (86.7% believed that screening for genetic risk in potential parents is
not wrong; 72.9% believed that all women planning a pregnancy should undergo a genetic test)
Fournier and Poulain
(2018)
Mostly negative. Some interests toward nutrigenetic tests have been identified (for curiosity, scientific progress, early diagnosis), but
much of the discussion has shown reluctance toward their adoption. Worries for dangerous use of the internet, criticism of science,
deterministic aspect, fear of knowing, desire/right not to know, ethical issues, attachment to French food models were expressed.
Metcalfe et al. (2018) Variable. Heterogeneous among participants. Positive attitude for tests for health conditions, especially for diseases for which there is
treatment/cure.
Horrow et al. (2019) Mostly positive. Most respondents attributed high value to their potential genetic test results. Some participants (35.2%) did express
concern about the confidentiality of their genetic test results.
Pereira et al. (2019) Mostly positive. Most patients (77%) were interested in finding out if they had pharmacogenetic variants or other genetic variants that
were related to their health (73%).
Rebitschek et al. (2019) Variable about epigenetic testing aimed to assess personal cancer risk.
Participants’ arguments in favor of epigenetic cancer risk assessment covered three major beliefs: guidance on one’s individual medical
strategy, the development of coping strategies (empowerment) by knowing one’s risks, and a motivational push to healthier or more
conscious living.
Unnecessary worry about cancer risk and consequences, the uncertainty surrounding the test result, a perceived lack of test benefit
were the main concerns that were brought up against testing.
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Eventually, just a small number of included studies (10%, n = 4)
proved a medium-high or high knowledge level (Waters et al.,
2014, 2016; Schmidlen et al., 2016; Horrow et al., 2019).
Several studies included in our review reported a correlation
between citizens’ level of knowledge and some of their
socio-demographic characteristics. Mai et al. reported that
individuals living in villages had poorer awareness about the
existence (61.5%) and the biological role (16.9%) of DNA
compared to individuals living in cities (93.7 and 80.8%
respectively) (Mai et al., 2011). A similar trend was observed
for age, with respondents aged <35 years more likely to
be aware of the existence (94.6%) and the biological role
(85.5%) of DNA compared to individuals older than 60 (86.6
and 60% respectively) (Mai et al., 2011). Kaphingst et al.
reported a significantly lower genetic knowledge among older
participants compared to younger participants, but also that
Black participants had lower genetic knowledge than White
participants (Kaphingst et al., 2016). Lastly, 2 studies investigated
the correlation between citizens’ educational attainment and the
effects on genetic literacy. In particular, the first one reported
that knowledge about limitations of genome sequencing was
higher among individuals with any post-graduate education
(odds ratio, OR: 8.7; 95% confidence interval, CI: 2.45–31.10) and
with a college degree (OR: 3.9; 95% CI: 1.05–14.61) compared
to individuals with an education level lower than a college
degree (Kaphingst et al., 2012). Instead, the last one reported a
correlation (Pearson correlation coefficient, r: 0.357; p < 0.001)
between higher education level (ranging from less than high
school to bachelor or higher) and better genetic knowledge
(Abrams et al., 2015).
Sources of Citizens’ Information
Two studies (5%) investigated the main sources of citizens’
information (Goddard et al., 2007; Kolor et al., 2012; Table 2).
Goddard et al. in a study published in 2007 and focused on
DTC nutrigenetic tests, pointed out that TV (for 46% of survey
respondents), magazines (35%), and newspaper (29%) were
the major sources of information among study participants.
Similarly, Kolor et al. (2012) showed that most commonly
interviewed people read or listened about DTC-GTs on TV or
radio, newspapers or magazines, and internet, in this order.
Attitudes
The topic of citizens’ perceptions about benefits and risks related
to the use of genomics or omics sciences in medicine was
investigated by 56% (n= 30) of the studies included (Henneman
et al., 2006, 2013; Skirton et al., 2006; Calsbeek et al., 2007;
Morren et al., 2007; Ishiyama et al., 2008; Makeeva et al., 2009;
Morin, 2009; Stewart-Knox et al., 2009; Hahn et al., 2010; Lemke
et al., 2010; Nielsen and El-Sohemy, 2012; Bombard et al.,
2013; Haga et al., 2013; Nicholls et al., 2013; Almeling, 2014;
Vermeulen et al., 2014; Etchegary et al., 2015; Kaphingst et al.,
2015, 2016; Mavroidopoulou et al., 2015; Mählmann et al., 2016;
McCormack et al., 2016; Miyamoto et al., 2016; Simonstein and
Mashiach-Eizenberg, 2016; Fournier and Poulain, 2018; Metcalfe
et al., 2018; Horrow et al., 2019; Jones et al., 2019; Middleton
et al., 2020; Table 3). Most of them (59%, n = 16) showed that
participants perceived benefits and usefulness from the use of
genomics and omics science in medicine (Skirton et al., 2006;
Morren et al., 2007; Makeeva et al., 2009; Morin, 2009; Stewart-
Knox et al., 2009; Hahn et al., 2010; Lemke et al., 2010; Nielsen
and El-Sohemy, 2012; Bombard et al., 2013; Nicholls et al., 2013;
Almeling, 2014; Mählmann et al., 2016; McCormack et al., 2016;
Miyamoto et al., 2016; Simonstein and Mashiach-Eizenberg,
2016; Metcalfe et al., 2018). In detail, perceived benefits
concentrated in the fields of prevention (lifestyle modification)
and treatment (personalization of treatment) (Morren et al.,
2007; Morin, 2009; Hahn et al., 2010; Nielsen and El-Sohemy,
2012; Bombard et al., 2013; Nicholls et al., 2013; Miyamoto et al.,
2016), and in general were related to a potential improvement in
life expectancy (Henneman et al., 2006; Makeeva et al., 2009).
The vast majority of study participants report concern on
the privacy and use, sharing and access to data (Stewart-Knox
et al., 2009; Lemke et al., 2010; Nicholls et al., 2013; Etchegary
et al., 2015; Mavroidopoulou et al., 2015; Mählmann et al., 2016;
Miyamoto et al., 2016; Metcalfe et al., 2018; Jones et al., 2019;
Middleton et al., 2020), and job discriminations (Henneman
et al., 2006; Makeeva et al., 2009; Lemke et al., 2010; Almeling,
2014; Metcalfe et al., 2018) or insurance issues (Calsbeek et al.,
2007; Morren et al., 2007; Lemke et al., 2010; Haga et al.,
2013; Henneman et al., 2013; Miyamoto et al., 2016; Middleton
et al., 2020). Three studies (Morren et al., 2007; Haga et al.,
2013; Miyamoto et al., 2016) reported public’s concern regarding
potential consequences of genetic testing results, or in general
personal genomics information, on working and professional life.
Further issues and concern included costs (Hahn et al., 2010;
Bombard et al., 2013; Nicholls et al., 2013; Metcalfe et al., 2018),
access to tests and feasibility of the introduction of genetic tests
in the health service (Bombard et al., 2013), and psychological
distress, fears, and anxiety potentially caused by genetic test
results (Skirton et al., 2006; Mählmann et al., 2016).
Regarding perceptions on genetic or omics tests (Table 4),
investigated by 52% (n = 28) of the studies (Henneman et al.,
2006, 2013; Skirton et al., 2006; Calsbeek et al., 2007; Morren
et al., 2007; Makeeva et al., 2009; Morin, 2009; Stewart-Knox
et al., 2009; Hahn et al., 2010; Mai et al., 2011; Nielsen and
El-Sohemy, 2012; Bombard et al., 2013; Haga et al., 2013;
Nicholls et al., 2013; Almeling, 2014; Vermeulen et al., 2014;
Etchegary et al., 2015; Graves et al., 2015; Kaphingst et al., 2015;
Mavroidopoulou et al., 2015; Mählmann et al., 2016; Miyamoto
et al., 2016; Simonstein and Mashiach-Eizenberg, 2016; Fournier
and Poulain, 2018; Metcalfe et al., 2018; Horrow et al., 2019;
Pereira et al., 2019; Rebitschek et al., 2019), 39% of them
highlighted overall positive attitudes among involved individuals
(Skirton et al., 2006; Calsbeek et al., 2007; Makeeva et al., 2009;
Morin, 2009; Stewart-Knox et al., 2009; Mai et al., 2011; Nielsen
and El-Sohemy, 2012; Mavroidopoulou et al., 2015; Mählmann
et al., 2016; Simonstein and Mashiach-Eizenberg, 2016; Horrow
et al., 2019). However, in 43% of the studies a clear position
toward the use of these tests is missing, hence their use in
clinical practice remains controversial (Henneman et al., 2006,
2013; Morren et al., 2007; Hahn et al., 2010; Bombard et al.,
2013; Haga et al., 2013; Nicholls et al., 2013; Vermeulen et al.,
2014; Kaphingst et al., 2015; Miyamoto et al., 2016; Metcalfe
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et al., 2018; Rebitschek et al., 2019). Moreover, in contrast with
the spread of DTC-GTs, the importance of pre- and post-test
genetic counseling was underlined (Morin, 2009; Mai et al., 2011;
Almeling, 2014; Mavroidopoulou et al., 2015).
In several studies, participants reported that genetic tests
would be appropriate only if used for the diagnosis of treatable or
preventable diseases (Morren et al., 2007; Vermeulen et al., 2014;
Graves et al., 2015; Metcalfe et al., 2018). Furthermore, according
to the study of Graves et al. (2015) the disease severity was also
reported as an important parameter in deciding which test results
are to be known (Covolo et al., 2015).
Educational Needs
Twenty percent (n = 11) of the studies endorsed the issue of
citizens’ education (Table 2; Skirton et al., 2006; Morin, 2009;
Hahn et al., 2010; Lemke et al., 2010; Dijkstra et al., 2012; East
et al., 2012; Bombard et al., 2013; Etchegary et al., 2015; Kaphingst
et al., 2015; Fournier and Poulain, 2018; Rebitschek et al., 2019).
Most of them (82%, n = 9) highlighted a clear educational need
to be fulfilled (Skirton et al., 2006; Morin, 2009; Hahn et al.,
2010; Lemke et al., 2010; East et al., 2012; Bombard et al., 2013;
Etchegary et al., 2015; Fournier and Poulain, 2018; Rebitschek
et al., 2019), showing however a lack of proactivity in information
seeking (Dijkstra et al., 2012). General population’s education
should focus, according to study participants, on the following
main topics: genetic/genomics research (Hahn et al., 2010; Lemke
et al., 2010; Dijkstra et al., 2012; Etchegary et al., 2015), disease
etiology and susceptibility (Hahn et al., 2010; Kaphingst et al.,
2015; Rebitschek et al., 2019), nutrigenomics (Morin, 2009), and
genetic and omics tests (Fournier and Poulain, 2018; Rebitschek
et al., 2019).
Furthermore, the importance of informed consent process as
an educational moment (Kaphingst et al., 2012) and the priority
and usefulness to pay particular attention to individuals at high
risk for specific diseases, “isolated groups” (e.g., low income,
ethnic minorities), youth and students were underlined (Lemke
et al., 2010).
Moreover, during focus groups described by Lemke et al.
several information strategies were suggested by participants,
such as evening TV news, internet, and focus groups (Lemke
et al., 2010).
Lastly, 4 studies (8%) investigated methods to increase
citizens’ literacy, such as Science Cafés with genomics experts
(Ahmed et al., 2017), education courses on specific genetic and
ethic topics (Gleason et al., 2010), short courses held by experts
(East et al., 2012), and an institutional web information portal
(Gleason et al., 2010). The comparison of described experiences
doesn’t allow to establish the most effective method to improve
general population’s literacy, due to the lack of quantitative
analysis and the heterogeneity of initiatives and topics dealt with.
DISCUSSION
This review aimed to describe current literature about citizens’
knowledge, attitudes, and educational needs in the field of omics
sciences. We performed a systematic literature search and we
identified studies published from 2006 onward, few years later
than the completion of HGP in 2003 (International Human
Genome Sequencing Consortium, 2004). Most of them were
conducted in USA (Fomous et al., 2006; Goddard et al., 2007,
2009; Gleason et al., 2010; Hahn et al., 2010; Lemke et al.,
2010; East et al., 2012; Kaphingst et al., 2012, 2015, 2016; Kolor
et al., 2012; Haga et al., 2013; Almeling, 2014; Borzekowski
et al., 2014; Waters et al., 2014, 2016, 2017; Abrams et al., 2015;
Dodson et al., 2015; Graves et al., 2015; Schmidlen et al., 2016;
Ahmed et al., 2017; Krakow et al., 2017; Horrow et al., 2019)
and fewer in European Union (Henneman et al., 2006, 2013;
Calsbeek et al., 2007; Morren et al., 2007; Mai et al., 2011;
Smerecnik et al., 2011; Dijkstra et al., 2012; Vermeulen et al.,
2014; Mavroidopoulou et al., 2015; McCormack et al., 2016;
Fournier and Poulain, 2018; Rebitschek et al., 2019). The main
promoters of identified initiatives were universities (Fomous
et al., 2006; Henneman et al., 2006; Skirton et al., 2006; Morren
et al., 2007; Morin, 2009; Stewart-Knox et al., 2009; Hahn et al.,
2010; Mai et al., 2011; Smerecnik et al., 2011; Nielsen and El-
Sohemy, 2012; Bombard et al., 2013; Haga et al., 2013; Nicholls
et al., 2013; Almeling, 2014; Borzekowski et al., 2014; Vermeulen
et al., 2014; Waters et al., 2014, 2016, 2017; Dodson et al.,
2015; Etchegary et al., 2015; Graves et al., 2015; Kaphingst et al.,
2015, 2016; Mavroidopoulou et al., 2015; Mählmann et al., 2016;
Miyamoto et al., 2016; Schmidlen et al., 2016; Simonstein and
Mashiach-Eizenberg, 2016; Fournier and Poulain, 2018; Metcalfe
et al., 2018), enlightening the high interest of the scientific
community for genomics and omics science implications for
citizens and patients.
Main tools used to investigate citizens’ attitudes, knowledge,
and educational needs were questionnaires or surveys
(Henneman et al., 2006, 2013; Calsbeek et al., 2007; Goddard
et al., 2007, 2009; Morren et al., 2007; Ishiyama et al., 2008;
Makeeva et al., 2009; Molster et al., 2009; Stewart-Knox et al.,
2009; Sturgis et al., 2010; Mai et al., 2011; Smerecnik et al., 2011;
Dijkstra et al., 2012; East et al., 2012; Kaphingst et al., 2012, 2015,
2016; Kolor et al., 2012; Nielsen and El-Sohemy, 2012; Haga et al.,
2013; Almeling, 2014; Borzekowski et al., 2014; Vermeulen et al.,
2014; Waters et al., 2014, 2016; Abrams et al., 2015; Dodson et al.,
2015; Etchegary et al., 2015; Graves et al., 2015; Mavroidopoulou
et al., 2015; Mählmann et al., 2016; Miyamoto et al., 2016;
Schmidlen et al., 2016; Simonstein and Mashiach-Eizenberg,
2016; Krakow et al., 2017; Horrow et al., 2019; Jones et al., 2019;
Pereira et al., 2019; Middleton et al., 2020) and, less frequently,
residential events (Skirton et al., 2006; Morin, 2009; Hahn et al.,
2010; Lemke et al., 2010; Bombard et al., 2013; Nicholls et al.,
2013; Etchegary et al., 2015; McCormack et al., 2016; Ahmed
et al., 2017; Waters et al., 2017; Fournier and Poulain, 2018;
Metcalfe et al., 2018; Jones et al., 2019; Rebitschek et al., 2019).
Just in few cases more innovative methods, such as a movie or a
short video (Sturgis et al., 2010; Mählmann et al., 2016) or a web
portal regarding genomics and its implications (Fomous et al.,
2006), were adopted.
The results of the present systematic review show that citizens’
knowledge on omics is generally poor or very poor (Skirton et al.,
2006; Calsbeek et al., 2007; Goddard et al., 2007, 2009; Morren
et al., 2007; Ishiyama et al., 2008; Molster et al., 2009; Morin,
2009; Gleason et al., 2010; Hahn et al., 2010; Lemke et al., 2010;
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Smerecnik et al., 2011; Dijkstra et al., 2012; East et al., 2012;
Nielsen and El-Sohemy, 2012; Almeling, 2014; Borzekowski et al.,
2014; Abrams et al., 2015; Etchegary et al., 2015; Mavroidopoulou
et al., 2015; Mählmann et al., 2016; Simonstein and Mashiach-
Eizenberg, 2016; Ahmed et al., 2017; Waters et al., 2017; Metcalfe
et al., 2018; Jones et al., 2019). Thus, a clear need for improving
citizens’ literacy is evident, even to avoid risks deriving from
inappropriate use of omics technologies (Ricciardi and Boccia,
2017; Boccia et al., 2019). The long time period covered by our
systematic review, starting with the beginning of the omics era
interestingly shows that over some 15 years only one study from
2019 of Horrow et al. (2019) reports a high level of awareness and
knowledge about genomics. As the participants in this study took
part in a genome sequencing project, this result is not surprising
and points out that an adequate information associated with
active citizen involvement improves not only knowledge but also
perception and attitudes on omics sciences and, in particular,
about genetic/omics tests.
Moreover, several studies investigated which
sociodemographic factors can correlate with citizens’ knowledge
level and literacy. In particular, a positive association was shown
with education (Kaphingst et al., 2012; Abrams et al., 2015)
and younger age (Mai et al., 2011; Kaphingst et al., 2016).
Furthermore, a lower knowledge level was shown in individuals
residing in suburban and extraurban areas, compared with
individuals living in cities (Mai et al., 2011).
Main sources of information resulted to be TV, magazines,
newspapers, and internet, rather than healthcare professionals.
This highlights the need for increasing literacy, not only for
citizens, who should be better informed about where and
from whom to seek trusted information, but for healthcare
professionals too (Ricciardi and Boccia, 2017), in order to
allow them interact with patients and give them satisfactory
explanations (Boccia et al., 2017).
The present systematic review provides relevant information
about citizens’ perceptions regarding benefits and risks related to
the use of genomics or omics sciences in the medical field too. In
particular, most of the studies showed that participants perceived
benefits and usefulness from the use of genomic and omics
science in medicine (Skirton et al., 2006; Morren et al., 2007;
Makeeva et al., 2009; Morin, 2009; Stewart-Knox et al., 2009;
Hahn et al., 2010; Lemke et al., 2010; Nielsen and El-Sohemy,
2012; Bombard et al., 2013; Nicholls et al., 2013; Almeling, 2014;
Mählmann et al., 2016; McCormack et al., 2016; Miyamoto et al.,
2016; Simonstein and Mashiach-Eizenberg, 2016; Metcalfe et al.,
2018). In detail, perceived benefits concentrated in the fields of
prevention and treatment (Morren et al., 2007; Morin, 2009;
Hahn et al., 2010; Nielsen and El-Sohemy, 2012; Bombard et al.,
2013; Nicholls et al., 2013; Miyamoto et al., 2016), and in general
were related to a potential improvement in life expectancy
(Henneman et al., 2006; Makeeva et al., 2009). Instead, the main
concerns of citizens relate to the privacy and use, sharing and
access to data (Stewart-Knox et al., 2009; Lemke et al., 2010;
Nicholls et al., 2013; Etchegary et al., 2015;Mavroidopoulou et al.,
2015; Mählmann et al., 2016; Miyamoto et al., 2016; Metcalfe
et al., 2018; Jones et al., 2019; Middleton et al., 2020), job
discriminations (Henneman et al., 2006; Makeeva et al., 2009;
Lemke et al., 2010; Almeling, 2014; Metcalfe et al., 2018), and
the insurance issues (Calsbeek et al., 2007; Morren et al., 2007;
Lemke et al., 2010; Haga et al., 2013; Henneman et al., 2013;
Miyamoto et al., 2016; Middleton et al., 2020). Other concerns
are related to potential consequences of genetic information on
working and professional life (Morren et al., 2007; Haga et al.,
2013;Miyamoto et al., 2016), costs (Bombard et al., 2013; Nicholls
et al., 2013; Metcalfe et al., 2018), access to tests and feasibility of
the introduction of genetic tests into clinical practice (Bombard
et al., 2013). Few studies have also reported psychological distress
in citizens potentially caused by genetic test results (Skirton et al.,
2006; Mählmann et al., 2016).
Overall, a positive attitude toward genetic or omics tests was
described (Skirton et al., 2006; Calsbeek et al., 2007; Makeeva
et al., 2009; Morin, 2009; Stewart-Knox et al., 2009; Mai et al.,
2011; Nielsen and El-Sohemy, 2012; Mavroidopoulou et al., 2015;
Mählmann et al., 2016; Simonstein and Mashiach-Eizenberg,
2016; Horrow et al., 2019), even though with some concerns
(Henneman et al., 2006, 2013; Morren et al., 2007; Hahn et al.,
2010; Bombard et al., 2013; Haga et al., 2013; Nicholls et al., 2013;
Vermeulen et al., 2014; Kaphingst et al., 2015; Miyamoto et al.,
2016; Metcalfe et al., 2018; Rebitschek et al., 2019). Furthermore,
the important role of pre- and post-test genetic consultation
was underlined (Morin, 2009; Mai et al., 2011; Almeling, 2014;
Mavroidopoulou et al., 2015). Some studies highlighted that key
points for appropriateness of genetic tests are curability and
preventability of the disease they are addressed to Morren et al.
(2007), Vermeulen et al. (2014), Graves et al. (2015), Metcalfe
et al. (2018).
Moreover, the few studies investigating need or request for
more education or information on genomics or omics sciences
among the population highlighted a clear lack to be fulfilled
(Skirton et al., 2006; Morin, 2009; Hahn et al., 2010; Lemke
et al., 2010; East et al., 2012; Bombard et al., 2013; Etchegary
et al., 2015; Fournier and Poulain, 2018; Rebitschek et al., 2019).
The main identified topics to focus for citizens’ education were
genetic/genomic research (Hahn et al., 2010; Lemke et al., 2010;
Dijkstra et al., 2012; Etchegary et al., 2015), disease etiology
and susceptibility (Hahn et al., 2010; Kaphingst et al., 2015;
Rebitschek et al., 2019), nutrigenomics (Morin, 2009), and
genetic and omics tests (Fournier and Poulain, 2018; Rebitschek
et al., 2019).
Our results show also a set of potential information strategies,
such as TV news, internet, and focus groups (Lemke et al.,
2010), Science Cafés with genomic experts (Ahmed et al., 2017),
education courses on specific genetic and ethic topics (Gleason
et al., 2010), short courses held by experts (East et al., 2012),
and an institutional web information portal (Gleason et al.,
2010). However, unfortunately it was not possible to establish
quantitatively the most effective method to improve citizens’
literacy in omics sciences field.
Notably, we found no study focusing on omics sciences other
than genomics and genetics or genetic tests. This could be
due to genomic applications being more widespread than other
omics technologies, which are probably still less known and
more difficult to understand by the general population. Based
on this knowledge gap, the planning of education programs for
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citizens should pay more attention to these issues and provide
clear and accurate definitions of the different omics sciences
and related tests. Indeed, an important aspect to take into
consideration in the information/training process aimed at the
general population is also the terminological consistency to be
used and disseminated (Martin et al., 2020). Indeed, this is a
key aspect for citizen empowerment, since the terminological
inappropriateness or variety of scientific definitions could cause
great confusion among citizens, especially in a field as complex as
that of the omics sciences.
To our knowledge, no previous systematic review attempted
to assess citizens’ knowledge and attitudes in the wide field
of omics sciences. We included also studies related to the
field of nutrigenomics, genomics research, and biobanking.
Furthermore, to date we do not yet have adequate information
on the educational needs of the general population in these fields.
However, our study has several limitations too. In particular,
due to the high heterogeneity among studies, it was not
possible to summarize quantitatively investigated issues, even
though we believe we appropriately summarize here our findings
qualitatively. In addition, we included studies conducted on
a limited number of participants which therefore may be not
representative of the general population. Another limitation of
the study is represented by the heterogeneity of the “citizens”
studied in the papers like patients suffering from different
diseases, participants in sequencing (biobank) projects, users of
DTC-GTs etc. The different “citizens” studied obviously have
different knowledge levels and training needs that must be taken
into account in planning a training strategy for the general
population. Also, there may be an insufficient understanding by
the general population of “omics sciences” as merely “genetic.”
This, however, seems to be kind of a general perception, also by
professionals. The results of the present systematic review show
that citizens’ knowledge on omics is generally poor or very poor
(Morin, 2009; Hahn et al., 2010; Lemke et al., 2010; Dijkstra et al.,
2012; Metcalfe et al., 2018) though some papers show moderate
knowledge of citizens on basic genetics and genetic testing (Mai
et al., 2011; Haga et al., 2013; Schmidlen et al., 2016; Waters et al.,
2016; Krakow et al., 2017) and the interest of the population on
these issues is emerging (Skirton et al., 2006; Morin, 2009; Hahn
et al., 2010; Lemke et al., 2010; Dijkstra et al., 2012; East et al.,
2012; Bombard et al., 2013; Etchegary et al., 2015; Kaphingst
et al., 2015; Fournier and Poulain, 2018; Rebitschek et al., 2019).
These data, however, underline an important educational gap to
be bridged in order tomake all stakeholders (health professionals,
decision makers, citizens, etc.) understand what omics sciences
are and what their potential is for public health.
Additionally, the studies included in our systematic review
were conducted in North America, the EU, the United Kingdom,
Switzerland, Russia, Australia, Japan and Israel, and three
studies were conducted “in various countries.” Therefore, our
results are clearly biased toward Western culture and may not
be representative of the world population. Due to the high
heterogeneity among studies, it was not possible to give a clear
differentiation of the range of application of our findings for the
different world parts and cultures and further research will be
needed aimed at defining the educational needs of citizens in the
various countries. However, the aim of our study was to highlight
current knowledge on citizens’ literacy, attitudes, and educational
needs on omics sciences, underlining the need for strengthening
public engagement on this topic.
Despite the limitations described, our study provides
important indications for fostering research and innovation in
the field of omics sciences. In particular, it allows us to confirm
citizens’ literacy but also the capacity building of healthcare
professionals in omics sciences field as a priority for action
for health systems around the world. Healthcare professionals
should be the main actors in the information process of citizens,
especially in complex fields such as that of the omics sciences.
The results of our review show that main sources of information
for citizens resulted to be TV, magazines, newspapers, and
internet. Therefore, an adequate training of health professionals
is necessary not only to ensure the correct application of omics
sciences in clinical practice, but also for correct information for
end users and, therefore, for patients and citizens.
Furthermore, our systematic review identified the
main elements to be considered for the development and
implementation of new training strategies for citizens in the field
of omics sciences. Specifically, based on the evidence collected
(Tables 1–4), a training activity on omics sciences aimed at
citizens must take into account the following items:
1. Target population to be trained. Training can be aimed at
the general population or at specific population groups such
as young or old people, students, individuals with specific
diseases (e.g., patients with multifactorial diseases, chronic
diseases, rare diseases, etc.), populations at greater risk for a
given condition than the general population, workers, etc.
2. Topics on which to train citizens. Main topics on which to
train citizens emerge from our study as the following: scientific
basis of genetics, disease etiology and genetic susceptibility,
genetic and non-genetic risk factors (environmental, lifestyle,
etc.) on the risk of disease; possibilities, implications and
future developments of genomics/omics research; genetic and
omics tests with particular focus on DTC-GTs; importance
of pre- and post-test genetic counseling; nutrigenomics and
correlated tests; “genomic medicine,” “personalized medicine,”
personalized approaches in the prevention of diseases; role
of the omics sciences in specific fields (e.g., oncology, aging,
cardiovascular, forensics); ethical implications associated with
genetic/omics research and the use of genetic/omics tests, etc.
3. Tools with which to train the population. Our results show also
a set of potential information strategies, such as TV news,
internet, focus groups, Science Cafés with genomics experts,
education courses on specific topics, short courses held by
experts, and institutional web information portal.
4. Professionals to be involved in the training of the population.
This aspect was not investigated in our review however
our study reveals that the main source of information for
citizens are TV, magazines, newspapers, and internet. These
data associated with the low level of citizens’ knowledge
in the omics sciences field further underlines the central
role that health professionals must have in the education
of citizens.
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The general understanding of omics and its benefits for medicine,
particularly in the context of personalized medicine, still appears
to be quite limited despite important scientific advances in this
field and the broadmarketing of DTC tests. However, considering
the broader context of “big” health data, understanding the omics
issues is evenmore complex and for the future implementation of
omics sciences in healthcare systems, educating of both citizens
and health professionals will be essential. Indeed, not all “experts”
could fully grasp the potential, challenges and issues at stake
if not properly trained. Healthcare is increasingly data-driven,
including omics. Therefore, health professionals will need to be
properly trained in order to enable to the patients more informed
health choices and ensure greater quality of healthcare (Fiske
et al., 2019).
Therefore, omics-based knowledge will be of utmost
importance for every healthcare practitioner, regardless of
the field of practice, as well as for citizens. Education will be
crucial for the effective and successful implementation of omics
sciences and it will have to evolve along with the changing
scientific landscapes.
Conclusions
Progress in genomics has clear and crucial implications for public
health. The current scientific context suggests a rapid transition
from conventional to personalized medicine. Therefore, a
strategic line to define the promotion and governance of omics-
related innovation is necessary.
In order to achieve this change, the involvement of all
stakeholders such as healthcare professionals, leaders, decision
and policy makers, and citizens, will be necessary. In addition,
the progress of the omics sciences is linked to the need to
develop a solid literacy of both healthcare professionals and
citizens. For this reason, effective tools of knowledge on the omics
sciences field, especially for citizens, will have to be identified
and implemented. Hence, further research should be fostered
in the future to allow the identification of appropriate and
effective methods for the design and implementation of large-
scale interventions aimed at improving citizens’ literacy and
engagement in the rapidly changing field of omics sciences.
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